Recombinant STEAP1 (Vandortuzumab Biosimilar) antibody

Catalog No. ABIN7795150

This anti-STEAP1 (Vandortuzumab Biosimilar) antibody is a Human Monoclonal antibody detecting STEAP1 (Vandortuzumab Biosimilar) in FACS and in vivo. Suitable for Human.

Quick Overview for Recombinant STEAP1 (Vandortuzumab Biosimilar) antibody (ABIN7795150)

Target: STEAP1 (Vandortuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This STEAP1 (Vandortuzumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-STEAP1 (Vandortuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Vandortuzumab Biosimilar, Anti-STEAP1 Monoclonal Antibody

Characteristics: The anti-STEAP1 monoclonal antibody vandortuzumab biosimilar was produced in mammalian cells.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for STEAP1 (Vandortuzumab Biosimilar)

Target: STEAP1 (Vandortuzumab Biosimilar)

Alternative Name: Vandortuzumab Biosimilar

Target Type: Biosimilar